The patient was found to meet the 2019 ACR/EULAR classification criteria for SLE [8] (positive ANA, fever, acute cutaneous lupus, oral ulcers, nonscarring alopecia, leukopenia, thrombocytopenia, anti-Sm antibodies, and low complement levels) and the 2016 ACR/EULAR classification criteria for Sjögren’s [9] (positive anti-SSA and positive Schirmer’s test), so a diagnosis of SLE overlap with Sjögren’s syndrome was made and the patient was started on hydroxychloroquine 200 mg daily. The gene discussed is BTG3; the disease is systemic lupus erythematosus.